Search Results - "Monzón Moreno, A"

6ER-020 Standardisation of processes by electronic assisted prescription programme in a university paediatric hospital by Pérez-Moreno, MA, Álvarez Del Vayo-Benito, C, Moleón-Ruiz, M, Alfaro-Lara, E, Araujo-Rodríguez, F, Monzón-Moreno, A

“…Background and importanceStandardisation of processes and electronic assisted prescription programmes (EAPP) are essential tools to prevent medication errors,…”
Get full text

Nuevos medicamentos en indicaciones ya cubiertas por otros medicamentos sin indicación oficial: dexametasona intravítrea y ranibizumab by Monzón Moreno, A.

Get full text

Treatment of neovascular age-related macular degeneration with bevacizumab by Monzón Moreno, A

Get full text

Bevacizumab en el tratamiento de la degeneración macular neovascular asociada a la edad by Monzón Moreno, A.

Get full text

Effectiveness and safety of adalimumab and etanercept for rheumatoid arthritis in a third-level hospital by Bernal Rivera, L, Guerrero Aznar, M D, Monzón Moreno, A, Beltrán García, M, Hernández Cruz, B, Colmenero, M A

“…To assess the effectiveness of adalimumab and etanercept at 6 and 12 months after therapy onset using DAS28, EULAR (European League Against Rheumatism), and…”
Get full text

New drugs for indications currently treated by off-label drugs: intravitreal dexamethasone and ranibizumab by Monzón Moreno, A

Get more information

Efectividad y seguridad de adalimumab y etanercept en artritis reumatoide en un hospital de tercer nivel by Bernal Rivera, L., Guerrero Aznar, M.D., Monzón Moreno, A., Beltrán García, M., Hernández Cruz, B., Colmenero, M.A.

“…Valorar la efectividad de adalimumab y etanercept a los 6 y 12 meses de tratamiento mediante DAS28, criterios EULAR (European League Against Rheumatism) y ACR…”
Get full text